Our goal is to unlock an inherent potential hidden in a possibility of highly clinically relevant experimental settings.
At Ti-com, our vision is to pioneer advancements in preclinical research by spearheading the development of image-guided procedures in large animal models. We aspire to revolutionize the field, striving to bridge the gap between preclinical studies and human applications. By leveraging cutting-edge imaging technologies, we aim to enhance precision in our research methodologies, ultimately contributing to the full implementation of precision medicine.
About Ti-com
Ti-com stands as a trailblazer in innovation, founded with the mission to transform groundbreaking academic achievements into commercial success and redefine preclinical large animal research. As a dynamic entity, Ti-com acts as a vital bridge connecting academic excellence with real-world impact, seamlessly translating cutting-edge research findings into the commercial sphere.
- Precision
- Pioneering
- Adaptability
Our commitment extends beyond conventional approaches, as we endeavor to refine and optimize the translation of results from animal models to humans. Through the integration of image-guided procedures, we seek to elevate the accuracy and relevance of our findings, laying the foundation for more effective and targeted medical interventions. This vision underscores our dedication to pushing the boundaries of preclinical research, with the ultimate goal of advancing the understanding and application of scientific discoveries for the benefit of human health.
Meet Our Amazing Team
The Ti-com team is comprised of highly skilled scientists with extensive expertise in large animal modeling, supported by a dedicated group of business advisors. Our professionals bring a wealth of experience to each project, ensuring it receives the utmost attention and proficiency. Specializing in preclinical research, the Ti-com team is committed to delivering comprehensive and tailored solutions. The collaboration with our business advisors enhances our strategic approach, leveraging their insights to optimize project success. Together, our team plays a pivotal role in contributing significantly to the success of every scientific endeavor.
CEO
Dominika Gołubczyk
Large animal intra-arterial
administration specialist
Co-founder
Piotr Walczak
Translational researcher
in precision medicine
Co-founder
Mirosław Janowski
Neurosurgeon by training,
scientist by passion
Chief Financial Officer
Maciej Daciewicz
Investment professional with over 20 years of experience
Scientific advisory board
Our preclinical CRO’s Scientific Advisory Board constitutes a global assembly of distinguished scientists, each possessing foundational expertise in animal modeling. This diverse and accomplished group unites professionals from various corners of the world, forming a collective brain trust that significantly elevates our organization’s capabilities.
Comprising experts in preclinical research and animal modeling, our Scientific Advisory Board plays a crucial role in guiding and shaping our research initiatives. Their extensive knowledge and international perspectives contribute to the development and implementation of cutting-edge strategies in the field of contract research. As a collaborative force, the board ensures that our organization remains at the forefront of scientific innovation, continuously refining and advancing our capabilities in preclinical research and large animal modeling.
Johanes Boltze
University of Warwick, England
Tim Magnus
Medical Center Hamburg-Eppendorf, Germany
Franklin West
University of Georgia, USA
Miguel Oliveira
University of Minho
Dileep Raghvendra Yavagal
University of Miami, USA
Jesus Ruiz – Cabello
CIC biomaGUNE
Careers
As we continue to grow, we are actively seeking talented individuals to join our dynamic team. Explore our open positions to become a part of our commitment to advancing scientific research. Your skills and passion could be the next valuable addition to our innovative and dedicated workforce. Check our Careers page for information on current job opportunities and how you can contribute to the impactful work we do at Ti-com.
Currently we don’t have job offers